Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eyenovia Inc (EYEN)

Eyenovia Inc (EYEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eyenovia Inc 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 USA

www.eyenoviabio.com Employees: 57 P: 833-393-6684

Description:

Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc. is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 9,085
Enterprise Value, $K -1,405
Shares Outstanding, K 86,442
Annual Sales, $ 4 K
Annual Net Income, $ -27,260 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -11,050 K
EBIT, $ -35,950 K
EBITDA, $ -34,480 K
60-Month Beta 1.75
% of Insider Shareholders 7.10%
% of Institutional Shareholders 25.84%
Float, K 80,305
% Float 92.90%
Short Volume Ratio 0.53

Growth:

1-Year Return -92.03%
3-Year Return -97.12%
5-Year Return -97.49%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 63.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.72
EPS Growth vs. Prev Qtr 38.89%
EPS Growth vs. Prev Year 38.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EYEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,108.24%
Return-on-Assets % -139.36%
Profit Margin % 0.00%
Debt/Equity -0.62
Price/Sales 184.12
Price/Cash Flow N/A
Price/Book 2.15
Book Value/Share -0.04
Interest Coverage -10.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar